Public Policy

Will Quebec’s Power Grab Fix Health Care—or Backfire?
Public Policy Will Quebec’s Power Grab Fix Health Care—or Backfire?

Quebec promised to fix access with a stroke of the pen, and in doing so it redrew the balance of power between government and physicians in a way Canada has rarely seen since medicare’s birth. The province’s new health law reset payment models, granted authorities the right to assign patients to pra

Rosen Law Firm Alerts MOH Investors to Class Action Deadline
Public Policy Rosen Law Firm Alerts MOH Investors to Class Action Deadline

A swift sequence of disclosures, market reactions, and legal milestones shaped a clear chronology for investors who bought Molina Healthcare, Inc. (NYSE: MOH) securities in early to mid-2025 and then saw risk details emerge that allegedly cut against prior guidance and cost trend assumptions,

Can Medicare Advantage Reforms Protect Seniors and Savings?
Public Policy Can Medicare Advantage Reforms Protect Seniors and Savings?

In a striking move to address growing concerns over healthcare for older Americans, a group of 13 Democratic House Representatives has introduced a comprehensive package of eight bills aimed at reforming Medicare Advantage (MA) and strengthening traditional Medicare. Led by Representative Mark

Will HSAs Replace ACA Credits in Health Care Reform?
Public Policy Will HSAs Replace ACA Credits in Health Care Reform?

As we dive into the complex world of health care reform, I’m thrilled to speak with Faisal Zain, a renowned expert in health policy with a deep understanding of the Affordable Care Act (ACA) and innovative approaches to insurance markets. With the potential expiration of enhanced premium tax c

Trump's Deportation Policies Disrupt Immigrant Healthcare
Public Policy Trump's Deportation Policies Disrupt Immigrant Healthcare

The landscape of immigrant life in the United States has undergone a seismic shift under President Donald Trump's second administration, with deportation policies casting a long shadow over communities nationwide. Reports of heightened fear and anxiety among immigrants—whether undocumented, h

FDA Approves Bayer's Hyrnuo to Rival Hernexeos in NSCLC
Public Policy FDA Approves Bayer's Hyrnuo to Rival Hernexeos in NSCLC

Introduction to a Shifting Landscape in Lung Cancer Treatment In the realm of oncology, non-small cell lung cancer (NSCLC) remains a formidable challenge, accounting for a significant portion of cancer diagnoses worldwide, and within this broad category, a small but critical subset—HER2-mutant N

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later